Chilcote; Tamie J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chilcote; Tamie J..The latest application filed is for "prevention and treatment of synucleinopathic and amyloidogenic disease".

Company Profile

2.12.20

Chilcote; Tamie J. - San Francisco CA
Chilcote; Tamie J. - San Fancisco CA
Chilcote; Tamie J - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20210032318 - Schenk; Dale B. ; et al.	2021-02-04
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20190300598 - SCHENK; DALE B. ; et al.	2019-10-03
Antibodies to Alpha Synuclein App 20180355028 - Chilcote; Tamie J. ; et al.	2018-12-13
Antibodies to alpha synuclein Grant 9,879,071 - Chilcote , et al. January 30, 2	2018-01-30
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20170349651 - Schenk; Dale B. ; et al.	2017-12-07
Antibodies to Alpha Synuclein App 20170204173 - Chilcote; Tamie J. ; et al.	2017-07-20
Treatment and delay of outset of synucleinopathic and amyloidogenic disease Grant 9,034,337 - Schenk , et al. May 19, 2	2015-05-19
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,506,959 - Schenk , et al. August 13, 2	2013-08-13
Antibodies to Alpha Synuclein App 20130072663 - Chilcote; Tamie J. ; et al.	2013-03-21
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease App 20120201842 - Schenk; Dale B. ; et al.	2012-08-09
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,147,833 - Schenk , et al. April 3, 2	2012-04-03
Alpha-synuclein kinase Grant 8,148,089 - Anderson , et al. April 3, 2	2012-04-03
Prevention and treatment of synucleinopathic and amyloidogenic disease Grant 8,092,801 - Schenk , et al. January 10, 2	2012-01-10
Alpha-synuclein Kinase App 20110207796 - Anderson; John P. ; et al.	2011-08-25
Treatment and delay of onset of synucleinopathic and amyloidogenic disease Grant 7,919,088 - Schenk , et al. April 5, 2	2011-04-05
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20100278814 - Schenk; Dale B. ; et al.	2010-11-04
Alpha-synuclein Kinase App 20100143946 - ANDERSON; JOHN P. ; et al.	2010-06-10
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20100031377 - Schenk; Dale B ; et al.	2010-02-04
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20090208487 - Schenk; Dale B. ; et al.	2009-08-20
Truncated Fragments of Alpha-Synuclein in Lewy Body Disease App 20090035217 - Chilcote; Tamie J. ; et al.	2009-02-05
Alpha-Synuclein Kinase App 20080300206 - Anderson; John P. ; et al.	2008-12-04
Prevention And Treatment of Synucleinopathic And Amyloidogenic Disease App 20080175838 - Schenk; Dale B. ; et al.	2008-07-24
Truncated fragments of alpha-synuclein in Lewy body disease Grant 7,358,331 - Chilcote , et al. April 15, 2	2008-04-15
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease App 20080014194 - Schenk; Dale B. ; et al.	2008-01-17
Truncated fragments of alpha-synuclein in Lewy body disease Grant 7,306,945 - Chilcote , et al. December 11, 2	2007-12-11
Truncated fragments of alpha-synuclein in Lewy Body Disease App 20060259986 - Chilcote; Tamie J. ; et al.	2006-11-16
Prevention and treatment of synucleinopathic and amyloidogenic disease App 20060058233 - Schenk; Dale B. ; et al.	2006-03-16
Truncated fragments of alpha-synuclein in Lewy body disease App 20050198694 - Chilcote, Tamie J. ; et al.	2005-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.